Equities

Henan Taloph Pharmaceutical Stock Co Ltd

600222:SHH

Henan Taloph Pharmaceutical Stock Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)4.27
  • Today's Change-1.20 / -21.94%
  • Shares traded5.13m
  • 1 Year change-32.86%
  • Beta1.2618
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Henan Taloph Pharmaceutical Stock Co Ltd (600222:SHH) closed at 4.27, 13.87% above the 52 week low of 3.75 set on Feb 08, 2024.
52-week range
Today
3.75Feb 08 20247.63Nov 24 2023
Open4.33
High4.36
Low4.26
Bid4.27
Offer4.28
Previous close5.47
Average volume19.27m
Shares outstanding573.89m
Free float411.02m
P/E (TTM)36.11
Market cap3.14bn CNY
EPS (TTM)0.1515
CNY
Annual div (ADY)0.018
CNY
Annual div yield (ADY)0.33%
Div ex-dateJul 09 2024
Div pay-dateJul 09 2024
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.